JMP Securities Boosts Halozyme Price Target On 'Long-Term Value'
June 04, 2015 at 10:17 AM EDT
In a report published Thursday, JMP Securities analyst Jason N Butler maintained a Market Outperform rating on Halozyme Therapeutics, ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.